Skip to main content
Top
Published in: Strahlentherapie und Onkologie 3/2019

01-03-2019 | Radiotherapy | Review Article

ICRU report 91 on prescribing, recording, and reporting of stereotactic treatments with small photon beams

Statement from the DEGRO/DGMP working group stereotactic radiotherapy and radiosurgery

Authors: Lotte Wilke, PhD, Nicolaus Andratschke, MD, Oliver Blanck, PhD, Thomas B. Brunner, MD, Stephanie E. Combs, MD, Anca-Ligia Grosu, MD, Christos Moustakis, PhD, Daniela Schmitt, PhD, Wolfgang W. Baus, PhD, Matthias Guckenberger, MD

Published in: Strahlentherapie und Onkologie | Issue 3/2019

Login to get access

Abstract

The International Commission on Radiation Units and Measurements (ICRU) report 91 with the title “prescribing, recording, and reporting of stereotactic treatments with small photon beams” was published in 2017. This extensive publication covers different relevant aspects of stereotactic radiotherapy such as small field dosimetry, accuracy requirements for volume definition and planning algorithms, and the precise application of treatment by means of image guidance. Finally, recommendations for prescribing, recording and reporting are given.
Literature
1.
go back to reference Seuntjens J, Lartigau EF, Cora S et al (2014) ICRU report 91. Prescribing, recording, and reporting of stereotactic treatments with small photon beams. J ICRU 14(2):1–160 Seuntjens J, Lartigau EF, Cora S et al (2014) ICRU report 91. Prescribing, recording, and reporting of stereotactic treatments with small photon beams. J ICRU 14(2):1–160
2.
go back to reference Jones D (1993) ICRU report 50. Prescribing, recording and reporting photon beam therapy. J ICRU 26(1):1–72 Jones D (1993) ICRU report 50. Prescribing, recording and reporting photon beam therapy. J ICRU 26(1):1–72
3.
go back to reference Landberg T, Chavaudra J, Dobbs J (1999) ICRU report 62. Prescribing, recording and reporting photon beam therapy (supplement to ICRU report 50). J ICRU 32(1):1–52 Landberg T, Chavaudra J, Dobbs J (1999) ICRU report 62. Prescribing, recording and reporting photon beam therapy (supplement to ICRU report 50). J ICRU 32(1):1–52
4.
go back to reference DeLuca P, Jones D, Gahbauer R et al (2010) ICRU report 83. Prescribing, recording, and reporting intensity-modulated photon-beam therapy (IMRT). J ICRU 10(1):1–107 DeLuca P, Jones D, Gahbauer R et al (2010) ICRU report 83. Prescribing, recording, and reporting intensity-modulated photon-beam therapy (IMRT). J ICRU 10(1):1–107
5.
go back to reference Guckenberger M, Andratschke N, Alheit H et al (2014) Definition of stereotactic body radiotherapy: principles and practice for the treatment of stage I non-small cell lung cancer. Strahlenther Onkol 190(1):26–33CrossRefPubMed Guckenberger M, Andratschke N, Alheit H et al (2014) Definition of stereotactic body radiotherapy: principles and practice for the treatment of stage I non-small cell lung cancer. Strahlenther Onkol 190(1):26–33CrossRefPubMed
6.
go back to reference Guckenberger M, Andratschke N, Dieckmann K et al (2017) ESTRO ACROP consensus guideline on implementation and practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer. Radiother Oncol 124(1):11–17CrossRefPubMed Guckenberger M, Andratschke N, Dieckmann K et al (2017) ESTRO ACROP consensus guideline on implementation and practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer. Radiother Oncol 124(1):11–17CrossRefPubMed
7.
go back to reference Kocher M, Wittig A, Piroth MD et al (2014) Stereotactic radiosurgery for treatment of brain metastases. A report of the DEGRO Working Group on Stereotactic Radiotherapy. Strahlenther Onkol 190(6):521–532CrossRefPubMed Kocher M, Wittig A, Piroth MD et al (2014) Stereotactic radiosurgery for treatment of brain metastases. A report of the DEGRO Working Group on Stereotactic Radiotherapy. Strahlenther Onkol 190(6):521–532CrossRefPubMed
8.
go back to reference Sterzing F, Brunner TB, Ernst I et al (2014) Stereotactic body radiotherapy for liver tumors: principles and practical guidelines of the DEGRO Working Group on Stereotactic Radiotherapy. Strahlenther Onkol 190(10):872–881CrossRefPubMed Sterzing F, Brunner TB, Ernst I et al (2014) Stereotactic body radiotherapy for liver tumors: principles and practical guidelines of the DEGRO Working Group on Stereotactic Radiotherapy. Strahlenther Onkol 190(10):872–881CrossRefPubMed
9.
go back to reference International Atomic Energy Agency (2017) Dosimetry of small static fields used in external beam radiotherapy. IAEA technical reports series, vol 483 International Atomic Energy Agency (2017) Dosimetry of small static fields used in external beam radiotherapy. IAEA technical reports series, vol 483
10.
go back to reference Deutsches Institut für Normung (2014) Klinische Dosimetrie – Teil 8: Dosimetrie kleiner Photonen-Bestrahlungsfelder. DIN 6809-8 Deutsches Institut für Normung (2014) Klinische Dosimetrie – Teil 8: Dosimetrie kleiner Photonen-Bestrahlungsfelder. DIN 6809-8
11.
12.
go back to reference Keall PJ, Mageras GS, Balter JM et al (2006) The management of respiratory motion in radiation oncology report of AAPM Task Group 76. Med Phys 33(10):3874–3900CrossRefPubMed Keall PJ, Mageras GS, Balter JM et al (2006) The management of respiratory motion in radiation oncology report of AAPM Task Group 76. Med Phys 33(10):3874–3900CrossRefPubMed
13.
go back to reference Benedict SH, Yenice KM, Followill D et al (2010) Stereotactic body radiation therapy: the report of AAPM Task Group 101. Med Phys 37(8):4078–4101CrossRefPubMed Benedict SH, Yenice KM, Followill D et al (2010) Stereotactic body radiation therapy: the report of AAPM Task Group 101. Med Phys 37(8):4078–4101CrossRefPubMed
14.
15.
go back to reference Moustakis C, Blanck O, Ebrahimi F et al (2017) Planning benchmark study for SBRT of early stage NSCLC: results of the DEGRO Working Group Stereotactic Radiotherapy. Strahlenther Onkol 193(10):780–790CrossRefPubMed Moustakis C, Blanck O, Ebrahimi F et al (2017) Planning benchmark study for SBRT of early stage NSCLC: results of the DEGRO Working Group Stereotactic Radiotherapy. Strahlenther Onkol 193(10):780–790CrossRefPubMed
16.
go back to reference Lambrecht M, Melidis C, Sonke JJ et al (2016) Lungtech, a phase II EORTC trial of SBRT for centrally located lung tumours – a clinical physics perspective. Radiat Oncol 11:7CrossRefPubMedPubMedCentral Lambrecht M, Melidis C, Sonke JJ et al (2016) Lungtech, a phase II EORTC trial of SBRT for centrally located lung tumours – a clinical physics perspective. Radiat Oncol 11:7CrossRefPubMedPubMedCentral
17.
go back to reference Andratschke N, Parys A, Stadtfeld S et al (2016) Clinical results of mean GTV dose optimized robotic guided SBRT for liver metastases. Radiat Oncol 11:74CrossRefPubMedPubMedCentral Andratschke N, Parys A, Stadtfeld S et al (2016) Clinical results of mean GTV dose optimized robotic guided SBRT for liver metastases. Radiat Oncol 11:74CrossRefPubMedPubMedCentral
18.
19.
go back to reference Brunner T, Nestle U, Adebahr S et al (2016) Simultaneous integrated protection: a new concept for high-precision radiation therapy. Strahlenther Onkol 192(12):886–894CrossRefPubMedPubMedCentral Brunner T, Nestle U, Adebahr S et al (2016) Simultaneous integrated protection: a new concept for high-precision radiation therapy. Strahlenther Onkol 192(12):886–894CrossRefPubMedPubMedCentral
20.
go back to reference Moustakis C, Blanck O, Ebrahimi F et al (2017) Time for standardization of SBRT planning through large scale clinical data and guideline-based approaches (In regard to Mancosu et al). Strahlenther Onkol 193(12):1068–1069CrossRefPubMed Moustakis C, Blanck O, Ebrahimi F et al (2017) Time for standardization of SBRT planning through large scale clinical data and guideline-based approaches (In regard to Mancosu et al). Strahlenther Onkol 193(12):1068–1069CrossRefPubMed
21.
go back to reference Lebredonchel S, Lacornerie T, Rault E et al (2017) About the non-consistency of PTV-based prescription in lung. Phys Med 44:177–187CrossRefPubMed Lebredonchel S, Lacornerie T, Rault E et al (2017) About the non-consistency of PTV-based prescription in lung. Phys Med 44:177–187CrossRefPubMed
22.
go back to reference Rieber J, Abbassi-Senger N, Adebahr S et al (2017) Influence of institutional experience and technological advances on outcome of stereotactic body radiation therapy for oligometastatic lung disease. Int J Radiat Oncol Biol Phys 98(3):511–520CrossRefPubMed Rieber J, Abbassi-Senger N, Adebahr S et al (2017) Influence of institutional experience and technological advances on outcome of stereotactic body radiation therapy for oligometastatic lung disease. Int J Radiat Oncol Biol Phys 98(3):511–520CrossRefPubMed
23.
go back to reference Tanadini-Lang S, Rieber J, Filippi AR et al (2017) Nomogram based overall survival prediction in stereotactic body radiotherapy for oligo-metastatic lung disease. Radiother Oncol 123(2):182–188CrossRefPubMed Tanadini-Lang S, Rieber J, Filippi AR et al (2017) Nomogram based overall survival prediction in stereotactic body radiotherapy for oligo-metastatic lung disease. Radiother Oncol 123(2):182–188CrossRefPubMed
24.
go back to reference Andratschke N, Alheid H, Allgäuer M et al (2018) The SBRT database initiative of the German Society for Radiation Oncology (DEGRO): patterns of care and outcome analysis of stereotactic body radiotherapy (SBRT) for liver oligometastases in 474 patients with 623 metastases. BMC Cancer 18(1):283CrossRefPubMedPubMedCentral Andratschke N, Alheid H, Allgäuer M et al (2018) The SBRT database initiative of the German Society for Radiation Oncology (DEGRO): patterns of care and outcome analysis of stereotactic body radiotherapy (SBRT) for liver oligometastases in 474 patients with 623 metastases. BMC Cancer 18(1):283CrossRefPubMedPubMedCentral
25.
go back to reference Guckenberger M, Klement RJ, Allgäuer M et al (2013) Applicability of the linear-quadratic formalism for modeling local tumor control probability in high dose per fraction stereotactic body radiotherapy for early stage non-small cell lung cancer. J Thorac Oncol 8(8):1050–1058CrossRefPubMed Guckenberger M, Klement RJ, Allgäuer M et al (2013) Applicability of the linear-quadratic formalism for modeling local tumor control probability in high dose per fraction stereotactic body radiotherapy for early stage non-small cell lung cancer. J Thorac Oncol 8(8):1050–1058CrossRefPubMed
26.
go back to reference Klement RJ, Allgäuer M, Appold S et al (2014) Support vector machine-based prediction of local tumor control after stereotactic body radiation therapy for early-stage non-small cell lung cancer. Int J Radiat Oncol Biol Phys 88(3):732–738CrossRefPubMed Klement RJ, Allgäuer M, Appold S et al (2014) Support vector machine-based prediction of local tumor control after stereotactic body radiation therapy for early-stage non-small cell lung cancer. Int J Radiat Oncol Biol Phys 88(3):732–738CrossRefPubMed
Metadata
Title
ICRU report 91 on prescribing, recording, and reporting of stereotactic treatments with small photon beams
Statement from the DEGRO/DGMP working group stereotactic radiotherapy and radiosurgery
Authors
Lotte Wilke, PhD
Nicolaus Andratschke, MD
Oliver Blanck, PhD
Thomas B. Brunner, MD
Stephanie E. Combs, MD
Anca-Ligia Grosu, MD
Christos Moustakis, PhD
Daniela Schmitt, PhD
Wolfgang W. Baus, PhD
Matthias Guckenberger, MD
Publication date
01-03-2019
Publisher
Springer Berlin Heidelberg
Keyword
Radiotherapy
Published in
Strahlentherapie und Onkologie / Issue 3/2019
Print ISSN: 0179-7158
Electronic ISSN: 1439-099X
DOI
https://doi.org/10.1007/s00066-018-1416-x

Other articles of this Issue 3/2019

Strahlentherapie und Onkologie 3/2019 Go to the issue